Skip to content
BY 4.0 license Open Access Published by De Gruyter March 1, 2022

Combatting persisted and biofilm antimicrobial resistant bacterial by using nanoparticles

  • Hassan A. Hemeg EMAIL logo

Abstract

Some bacteria can withstand the existence of an antibiotic without undergoing any genetic changes. They are neither cysts nor spores and are one of the causes of disease recurrence, accounting for about 1% of the biofilm. There are numerous approaches to eradication and combating biofilm-forming organisms. Nanotechnology is one of them, and it has shown promising results against persister cells. In the review, we go over the persister cell and biofilm in extensive detail. This includes the biofilm formation cycle, antibiotic resistance, and treatment with various nanoparticles. Furthermore, the gene-level mechanism of persister cell formation and its therapeutic interventions with nanoparticles were discussed.

1 General consideration about bio-films and persisted cells

Bacteria, the simplest organism, is the most ancient and one of the key components required by the biome, as it is responsible for the majority of work at lower levels, such as the micro level [1]. They adapted to every environment on the earth’s surface, from high-temperature volcanic regions to deep freezing environments, and they used plants and animals as a means of survival [2]. These bacteria existed in the form of a biofilm or a cell (planktonic), according to Refs. [1, 3], [4], [5], [6]. Biofilms differ from planktonic cells in composition because they live in nature, reproduce, and exist in colonies in three-layered structures such as complex three-dimensional (3D) shapes [1, 4, 5]. They are made up of a single or multiple bacterial species. Depending on the species and environment, it responds differently and exhibits similar properties [1, 3], [4], [5]. The bio-films are held together by a sticky mass known as extracellular polymeric substance (EPS), which is a polymer excreted by microbes. They can interact with biological and non-biological materials in both specific and non-specific ways [3, 5]. Bio-film cells produce a sticky mass of EPS that is strongly held together by these strands, giving them a complex, three-dimensional structure [4]. All biofilms vary in size and shape depending on environmental conditions, nutrient availability, and growth status [1, 3]. Bacterial cells are protected from technical accents due to the viscoelastic nature of biofilms [1, 5]. The biofilm growth cycle begins with the formation of bacterial cells and ends with the formation of new sister cells (Figure 1A) [6]. Throughout the cycle, biofilm serves as a mediator of cell signals as well as a medium for metabolic activities [6].

Figure 1: 
(A) This image depicts the formation of a bio-film and its attachment to biological and non-biological surfaces, as well as its adhesion, reproduction, and EPS secretion. Figure A also depicts the multilayer three-dimensional shape of a biofilm made up of major (nucleic acid, polysaccharides, protein) and minor (lipids, ions, water) components (B) The image depicts the effect of gold and silver nanoparticles and their ions on seven specific target sites within a bacterial cell. The molecular structure and bacterial cell are not to scale, but are represented arbitrarily for symbolic purposes.
Figure 1:

(A) This image depicts the formation of a bio-film and its attachment to biological and non-biological surfaces, as well as its adhesion, reproduction, and EPS secretion. Figure A also depicts the multilayer three-dimensional shape of a biofilm made up of major (nucleic acid, polysaccharides, protein) and minor (lipids, ions, water) components (B) The image depicts the effect of gold and silver nanoparticles and their ions on seven specific target sites within a bacterial cell. The molecular structure and bacterial cell are not to scale, but are represented arbitrarily for symbolic purposes.

Persister cells are resistant to antimicrobial treatments due to a decrease in metabolic activity, which is dependent on corrupting active biochemical pathways. As a result, some molecules responsible for the killing of bacterial persister cells should function properly. cisplatin and the DNA-crosslinker mitomycin C are included in the anti-bacterial precursor compound. Persisters’ function is to withstand stress caused by inactive metabolic activity [7], [8], [9], [10] and without genetics [11]. The nongrowing cell of Staphylococcus aureus that tolerates penicillin stress is a practical example of presister [7, 8]. As presister cells used to exist in a small subpopulation, they normally resist when mutagenic changes occur that allow the antibiotic to be used, whereas tolerance occurs when growth is reduced, making the entire population less susceptible to the antibiotic [12, 13]. Scientists tried to clear up the confusion regarding the literature of presisters [14], [15], [16], [17], [18]. They also tried to highlight the mistakes being made by the researchers by not waiting for the plateau in the graph where some viable cells retain and shoe the existence of presister cells [19]. It was reported that for selected bacteria such as enterophemorrhagic Escherichia coli and E. coli, the viable fraction is similar to that of their presister cells [16].

Persisters are made up of various components such as oxidative stress, nutrients, and antibiotics [16, 20]. The majority of cells are thought to be underfed [21], and in a persistence condition, archea and bacteria are thought to be in a resting stage [19]. Persistence used to exist in a limited capacity, but its response to the environment is highly regulated [22], [23], [24], [25], [26]. In biofilms and stationary-phase cultures, a small subpopulation (±1%) of stress-tolerant cells responds to the environment [27, 28].

2 Biofilm resistance formation and treatment using nanoparticles

2.1 Formation of bio-film formation its resistance effect

2.1.1 Cycle of bio-film showing its development

The biofilm development cycle begins with the formation of a 3D structure and the attachment of bacterial cells that exist freely on living or nonliving surfaces while keeping in mind the feasible environmental conditions and ends with the secretion of EPS in the 3D shape of biofilms [29]. The major component of biofilm is EPS, which accounts for approximately 90% of total biomass; biofilm is composed of lipids, protein nucleic acid, and carbohydrate polysaccharides [30]. The function of EPS is to keep biofilm bacteria together, as well as to allow cell-to-cell communication, gene transfer, and antibiotic resistance in bacteria. Furthermore, EPS provides minerals to bacteria, such as phosphorus, nitrogen, and carbon, in addition to the compounds [30]. When the biofilm progresses, the bacteria from the biofilm are excreted and dispersed from the colony, attempting to form new colonies in search of new and better nutrients [29]. Various plans and strategies were used at each stage of biofilm development. Mannosides, curlicides, and pilicides have been used as anti-adhesion agents, and some anti-biofilm polysaccharides can also be used to prevent bacteria from adhering to the surface [31], [32], [33], [34]. The maturation of biofilms and the formation of micro-colonies can also be delayed by using silver NPs, lytic phage, and some enzymes such as EPS-degrading enzymes [35, 36]. Before the natural dispersal of signals occurs, the bio-film bacterial cells spread out in the surrounding medium to control signal dispersion [37].

3 Resistance of bio-film and antibiotic

It was found that two years after the introduction of penicillin, resistance to the antibiotic effect took two years [38]. Antibiotic resistance has proven to be a challenge for the healthcare system, posing a burden on the system as a result of the widespread use of antibiotics [39], whereas biofilm is crucial in combating the health crisis.

Understanding the biofilm antibiotic resistance mechanism is critical for treating biofilm-related diseases. Antibiotics work in a much mechanized way as they attack the bacterial cell and target the cell wall biosynthesis, protein synthesis, and DNA replication and repair processes. According to the literature, bacterial cells show resistance to these attacks through a variety of mechanisms, including enzymes that deactivate antibiotics, efflux pumps, and reprogramming of antibiotic targets [39]. The function of efflux pumps is to pump antibiotics out of bacterial cells via membranes in order to reduce antibiotic concentrations within the cell. The role of enzymes in antibiotic resistance is also very beneficial because it deactivates antibiotics through specific modifications within their components. Antibiotics’ targeted sites are modified over time to avoid resemblance [38]. The antibiotic resistance of biofilm bacteria differs from that of planktonic bacteria, whereas the mechanisms of planktonic bacteria are easily understood. Understanding planktonic bacterial antibiotic resistance in comparison to biofilm bacteria is a difficult task. The aforementioned mechanism may exist in biofilms; these antibiotics work in a similar manner with various mechanisms for the specific mode of biofilm growth. While the correct mechanism is still being researched, scientists are working on several mechanisms to precisely explain the status of biofilm antibiotic resistance. Although some well-known mechanisms are mentioned in the literature, Stewart [40] is easily accessible. It was previously thought that the 3D structure of biofilm served as a physical barrier to prevent antibiotic diffusion within the body. However, recent research claims that antibiotic diffusion is unrelated to biofilm structure [41, 42]. Furthermore, other literature supports the hypothesis that once an antibiotic binds to the polysaccharides, proteins, and DNA present in the biofilm EPS, it becomes inactive on the targeted bacteria and loses its ability to kill them [43]. When bacterial cells are lysed, genetic components such as plasmids are released and remain in the media, enhancing the process of gene transfer among bacterial cells [33]. The plasmids contain antibiotic resistance genes, which are thought to be beneficial [44, 45] formalized paraphrase It was concluded that antibiotics such as beta-lactams are lysed by carbapenemases, which is the literature’s conformation for gene transfer resistance mechanism. Meanwhile, the interior structure of biofilm reveals that because it is anaerobic in nature, its bacteria have access to a limited supply of oxygen and other nutrients, making antibiotics less effective against bacterial killing [46]. Penicillin begins to disrupt bacterial cell synthesis; if the biofilm is not synthesizing a cell wall, penicillin will be ineffective. It is claimed that within biofilm, bacterial cells are in various stages of growth, allowing some populations of bacteria to survive antibiotic attack. According to Persister theory, very few bacterial cell populations are resistant to antibiotic attack, and intervention results in the incomplete killing of bacterial cells [47, 48]. Another mechanism used to control genes is quorum sensing, which controls genes by sensing local cell density [49], and which has also actively participated in the formation of Refs. [50], [51], [52], [53]. It is still unclear how the biofilm antibiotic is controlled by quorum sensing, but it has been reported that efflux pump genes use quorum sensing, as reported by Ref. [54]. The current literature also supports and points to a link between quorum sensing and antibiotic resistance [55]. There is very little literature mentioned here, demonstrating that it is a complex process (biofilm antibiotic resistance) and an alarming challenge.

4 Treatment of biofilms with nanoparticles

Two types of nanoparticles (NPs) should be used to combat bacterial infections. The first is made of lipids, polymers, and silica and serves as a drug delivery carrier to activate antibiotics, while the second is made of metallic NPs and serves as an antimicrobial agent. When used as a drug carrier, NPs protect antimicrobial agents from enzymes such as lactamases, function to prevent antimicrobial agents from sticking to EPS components such as DNA, and excrete antimicrobial agents in a controlled environment to reduce the harmful effect while also increasing antimicrobial efficiency. Using NPs not only targets antibiotic delivery but also improves bioavailability [56]. Figure 2 depicts the formulation and treatment of nanoparticles for biofilm-related problems [57], [58], [59], [60], [61], [62], [63], [64], [65], [66], [67], [68].

Figure 2: 
Treatment with nanoparticles has a variety of applications, including preventing, disrupting, inhibiting, or dispersing bacteria from biofilm infections.
Figure 2:

Treatment with nanoparticles has a variety of applications, including preventing, disrupting, inhibiting, or dispersing bacteria from biofilm infections.

5 Factors affecting microbial toxicity

Scientists are investigating the relationship between nanoparticles and microbes in order to determine the toxic effects of nanoparticles and how they relate to physical and chemical properties. Some of the properties of nanoparticles, such as physical properties, are thought to be interrelated, while irregular changes in structure, appearance, and surface coating can alter communication with biological systems. The biological impact of nanoparticles can also be influenced by other factors such as nanoparticle synthesis, dose, additive presence and absence, material solubility, and microbe internal properties.

6 Parent material

The nature of the parent materials determines microbial toxicity; the relative toxicity of one material in comparison to another varies due to differences in structure, size, surface coating, and synthesis method, all of which affect toxicity. Physical properties are difficult to control, whereas changes in surface coating can be caused by different synthesis methods and accidental toxic materials. Certain materials added during the manufacturing process, such as detergents, chemicals, and additives, remain within the product and are not completely eliminated, making the product toxic. According to the literature on engineered Ag nanoparticles on bacterial efficacy with specific surface coating and size using various techniques, solvent chemical usage may lead to the formation of false toxicity. For instance, in the Ag-resistant E. coli was used, which led to the death of Ag-resistant bacteria due to the use of formaldehyde remnants. As a result, it has been demonstrated that the biological properties of nanoparticles are dependent on the specific parts used in formulation or the one that differs from the rest during the chemical coating process on the nanoparticle [69]. Metal ions, which are required by living organisms in small amounts, can be toxic if used in high concentrations. It has also been reported that some metals have a low solubility rate in aqueous medium, and microbes face a challenge once the metal nanoparticles convert into ions [70, 71]. The mechanism of toxicity at the molecular level differs for different ions and species, and once the nanoparticle breaks up into ions, the nanoparticle may become toxic. The toxic effects of metal ions such as copper, silver, zinc, and nickel have long been recognized as a result of microbial toxicity. Meanwhile, the nanoparticles formed as a result of these ions have become toxic. Silver is a metal ion that is commonly used as a microbial toxic material, and much research has been done on the use of silver as an antimicrobial agent, either alone or in combination [72]. Previous research has also shown that the use of silver nanoparticles during breakup can have a toxic effect. The toxicity of nanoparticles and their dissolved ions has been observed in their other materials. It is also believed that some of the nanoparticles composed of iron, gold, palladium, silver sulfide, and platinum are nontoxic in nature. Because of their low solubility in aqueous media, their metal ions are nontoxic in nature. Based on the preceding discussion, it is concluded that the breakdown of nanoparticles into ions can result in toxicity. The generation of ROS is another reason for nanoparticle microbial toxicity. Some physical and chemically engineered nanoparticles have redox active surfaces and can react with oxygen at the molecular level to produce ROS, which are responsible for the toxic response of biological systems. Whereas metal or metal oxide nanoparticles have the ability to release ions, causing the ions to be toxic and also generating ROS, which is responsible for the toxicity of nanoparticles, the toxic effect of nanoparticles still requires further research due to unclear results [69].

7 Size and shape

The size and shape of nanoparticles are important factors that influence their toxicity. Size and shape are inversely related because reducing particle size increases surface area, which causes changes in the physical and chemical properties of the nanoparticle. As a result, toxic nanoparticles with smaller particle sizes form. The best examples are silver and zinc oxide nanoparticles, which are formed as particle reactivity increases. Other practical examples show that when nano-silver on nano-silica particles interacts with E. coli, size-dependent Ag ions are released. When the dimension of the fine particle to be used is less than 10 nm, the Ag+ is considered to be prominent. Another factor that can influence the properties of nanoparticles is shape. Particles with irregular shapes, rough and uneven surfaces exhibit approximately 10 antimicrobial activations, and it is also believed that the corners and edges (180) remain chemically and biologically active. The weak coordination of atoms at these sites has a significant impact on microorganism interactions. Different shapes of nanoparticles are engineered and commonly used by using different methods of synthesis, including rods, spheres, pentagons, triangles, squares, and hexagons. Certain literature has also supported the increased toxicity of a material due to the presence of highly reactive nanoparticles at its edges. For example, silver nanoplates in triangular shapes are thought to be more reactive against E. coli than particles in other shapes, such as spherical and rod-shaped [73].

8 Concentration

Higher concentrations of nanoparticles exhibit potent antimicrobial activity. As it performs various functions on the same microbial growth, such as mitochondrial dysfunction, increased enzyme activity (lactate dehydrogenase execration from the cell), and increased nanoparticle effect. Furthermore, a larger surface area can be covered by using a higher nanoparticle concentration, resulting in increased antimicrobial activity [74].

9 Roughness

Another factor that can influence the properties of nanoparticles on bacterial cells is roughness. As the roughness of a nanoparticle increases, so does its size and surface area-to-mass ratio, which increases bacterial protein adsorption and decreases bacterial adhesion [75], [76], [77].

10 Zeta potential

The zeta potential of nanoparticles has also been shown to improve bacterial adhesion. Nanoparticles have a positive charge, whereas bacteria’s cell membranes have a negative charge, which electrostatically attracts each other. Because of these positive charges, nanoparticles are prone to being adsorbed on the bacterial cell and are closely connected [78]. In contrast to the −ive charge, neutral charge, and +ive charge, they are thought to have been used to boost ROS production. According to recent literature, nanoparticles with negative charges do not adhere to bacterial membranes because they carry the same charge. Using higher concentrations of nanoparticles with −ive charges, antibacterial activity is demonstrated due to molecular crowding, demonstrating the connection between the bacterial surface and nanoparticle [79].

11 Doping modification

The goal of doping medication is to avoid nanoparticle clustering and thus allow it to remain diffuse within an aqueous or other hydrophilic solvent medium. By doping, the communication between nanoparticles and bacterial cells can also be effectively controlled and regulated in a specific manner. Combinations of ZnO and Au nanoparticles form a noncomposite compound called ZnO/Au, which not only increases ROS generation but also improves photocatalytic activity. These findings improve the following factors: increased light absorption due to Au wavelength; zinc oxide width changes with band gap, increasing the reactivity of photo-induced charge carriers; and improved separation of charge carrier and electron transport. The antibacterial activity changes as a result of doping modification. It is concluded that nanoparticles of zinc oxide doped with fluorine generate more ROS than zinc oxide nanoparticles alone, resulting in the death of bacterial cells. The O content at the surface of ZnO is thought to be the key factor in regulating antimicrobial activity against both gram-negative and gram-positive bacteria [80].

12 Surface coating

The nanoparticle is thought to be surrounded by a member or shell that acts as a reactive or stabilizing agent after modification. This member (surface) is regarded as a primary factor in determining a nanoparticle’s environmental and biological fate because it is an important component of contact. Surface coating can affect the charge on nanoparticles, which in turn can affect the material’s affinity. The surface charge of silver nanoparticles is thought to be the most important factor in their toxicity in nature. Different surface coatings were investigated, with results ranging from extremely positive to extremely negative, demonstrating that decreasing toxicity also reduced particle size [81]. Ion dissolution or release from nanoparticles is also caused by surface coating.

13 Particular properties of microorganisms

The effect of nanoparticles on microorganisms should be studied because they should not be similar. Several studies have been conducted to determine the response of nanoparticles to various bacterial species. It is estimated that approximately 10 antimicrobial nanoparticles activated have exerted 182 physiological characteristics on microbes that influence their growth and tolerance level to nanoparticle-induced stress. Different species of microorganisms react differently to toxic nanoparticles. Synthesized Ag nanoparticles were applied to gram-negative and gram-positive bacteria and compared, revealing that gram-negative E. coli and Shewanella oneidensis are more resistant than gram-positive Bacillus subtilis. Other studies on the susceptibility of gram-positive and gram-negative bacteria to nanoparticles have also been conducted [69]. According to the literature, gram-positive organisms are more sensitive to toxic nanoparticles due to their sensitive nature; this increased sensitivity is also due to differences in the cell membrane and cell wall of bacteria. Gram negative bacteria, on the other hand, are resistant to nanoparticles due to the presence of lipopolysaccharides on the bacterial cell’s outer membrane [82], [83], [84]. In a study comparing the toxicity of CdTe QDs to gram-negative and gram-positive bacterial strains, the gram-positive organism was found to be more sensitive than G −ve. The release of heavy metal ions was also observed; the formation of free hydroxyl radicals is a major cause of toxicity [85]. The sensitive nature of the QDS of gram-negative bacteria over gram-positive bacteria is debatable. Certain nanoparticles have varying degrees of toxicity to different microbes. Due to the lack of a lipopolysaccharide membrane, TiO2 and Ag–TiO2 nanoparticles have been shown to be more toxic to B. subtilis than P. putida [71]. Bacterial tolerance to nanoparticles improves as the number of bacterial cells increases. It was also discovered that bacteria that grow faster are more susceptible to antibiotics and nanoparticles than bacteria that grow slowly and steadily [86]. The tolerance properties of slow growing bacteria can be linked to the expression of stress response genes [87]. B. subtilis and P. putida are also capable of acquiring nC60. P. putida has the ability to reduce unsaturated fatty acid levels while increasing cyclopropane fatty acid levels, whereas B. subtilis has the ability to increase transition temperature and fluidity in the presence of nC60. These properties have been shown to protect bacterial membranes from oxidative stress. S. oneidensis MR-1, for example, provides a practical example of how much it aids in resistance to Cu2+ and Cu-doped TiO2 nanoparticles [88], which is due to the formation of EPS under nanoparticle stress. As it mops up nanoparticles on the cell surface, this bacterium can reduce the concentration of Cu ions in the media. These bacteria are also important because they are in charge of detoxifying metal oxide nanoparticles from the environment. Cupriavidus metallidurans CH34 and E. coli are normally internalized by compounds such as TiO2 and Al2O3 nanoparticles, whereas these nanoparticles are toxic only against E. coli [89]. The mechanism of resistance of C. metallidurans CH34 is still being studied. The bacterial tolerance mechanism mentioned above may be related to physical properties of their peptidoglycan layer and genes found in plasmids that have the ability to stabilize the plasma membrane of nanoparticles. Some bacteria are also capable of tolerating nitric oxide (NO) nanoparticles [73]. E. coli, Pseudomonas aeruginosa coli, and Salmonella typhimurium are two examples of such bacteria that are responsible for DNA repair and metal homeostasis changes in the presence of no nanoparticles. K is responsible for the production of the enzyme flavohemoglobin. Pneumonia, which counteracts nitrosative stress, furthermore, some microbes have the ability to produce biofilm, which serves to protect them from harm. Biofilms are thought to be complex 3D microbial colonies that form by adhering to a solid surface and secreting a matrix (EPs) that serves to protect and cover the bacterial cell colony. When Ag nanoparticles are exposed to biofilm, they may inhibit the growth of new bacterial colonies and thus the development of biofilm [90].

14 Environmental conditions

The effect of antimicrobial activity can be altered by a variety of environmental factors. The generation of ROS is an example of how environmental temperature affects antibacterial activity. Temperature is used to restore zinc oxide (ZnO) nanoparticles and thus electrons at the targeted site. Meanwhile, ROS is produced as a result of the electron-oxygen correlation, which effectively enhances the antimicrobial effect of ZnO nanoparticles. Furthermore, other environmental factors such as pH increase the effect of in vitro antimicrobial activity. The level of suspension rate of ZnO nanoparticles increases as the pH decreases. Whereas the mechanism of dissipation of Ag nanoparticles has also been proposed following the interchanging of Ag+ with oxygen and protons, Variation in aquatic chemistry causes the activation of Ag nanoparticles, which release Ag ions as a result of increased antibacterial activity. According to the findings of the study, nanoparticles are more soluble in acidic water (acetic acid) than in neutral water. pH and osmotic pressure, for example, have an effect on the surface charge, clustering, and solubility of nanoparticles. Antibacterial tests on ZnO nanoparticles were performed in five different media, indicating that their activity may be due to free Zn ions and zinc complexes. It is also concluded that the medium is responsible for supplying nutrients to bacteria in order to improve their tolerance to Nps. The antibacterial effect can also be controlled by various techniques for producing ZnO nanoparticles [80].

15 Persister cell formation

ppGpp is associated with persistence, as there is a close agreement on alarmoneppGpp for the generation of persisters [91], [92], [93], [94]. However, it is unknown what mechanism the ppGpp uses to form the persister cells. Understanding the mechanism that slows the metabolism rate of ppGpp will aid in understanding the relationship between ppGpp and persistence. It occurs as a result of the following factors: weather stress, cells slowing replication, transcription, and translation by synthesizing guanosine tetraphosphate and guanosine pentaphosphate [95]. ppGpp is also responsible for inhibiting DNA primase, which reduces DNA replication and transcription [95], as well as stimulating RpoS (sigmaS, the stress response sigma factor for the stationary phase) and RpoE (sigmaE, the stress response sigma factor for misfolded proteins in the periplasm) [96]. Purine nucleotide formation and purine homeostasis regulation were prevented by ppGpp through the action of the nucleosidase PpnN [97]. With a decrease in ribosome production, ppGpp translation rates also decrease [98].

ppGpp is also directly responsible for protein activity reduction, as it prevents and binds GTPases and GTPaseHflX [95]. It also binds to the protein GTPase HflX, which activates 100S ribosomes [99], and its property is to prevent inactive ribosomes from being reactivated. Furthermore, ribosomes that are linked to GTPase participate in the biogenesis of ribosome subunits, which is inhibited by ppGpp [15].

In the formation of precursor cells, ppGpp is used to inhibit the ribosomes in a variety of ways, including persuading rmf [100], which functions to encode RMF, which inactivates 70S ribosomes, (ii) inducing hpf, which encodes the hibernation promoting factor (Hpf), and (iii) inducing rai (RaiA). Other factors have also been discussed, such as how ppGpp is useful in activating the toxin system, which leads to persistence [101], [102], [103]. The use of a simpler ribosome dimerization persister (PRDP) model is being considered, which functions to generate persister cells directly via ppGpp without the use of TA systems, which convert 70S ribosomes into inactive 100S ribosomes as the ribosomes are inactivated [18, 19]. Using this model, it was determined that [19] i) ribosomes in presister cells are mostly inactive, just like 100S ribosomes. (ii) Inactivation of RMF, Hpf, and RaiA leads to the formation of persister cells, as well as an increase in single persister cell regeneration. (iii) ppGpp levels have no effect on single cell persister formation. This model has no effect on the TA system for persister cell formation because its link to persistence is unconvincing [104, 105]. Persistence occurs at lower levels of ppGpp, but as levels decrease [93], the model PRDP will behave like the cAMP function to idle Hpf and RMF, resulting in the generation of 100S and stagnant ribosomes. Famine (for example, glucose depletion) causes an increase in cAMP, prompt rmf [98], and raiA [106], while HflX is also suppressed by cAMP [107]. The cAMP model, like the ppGpp model, played a similar role in the generation of persister cells, with increased cell signal concentrations leading to inactivation of ribosomes and persistence.

16 Treatment for persister cells using nanoparticles

Different types of metallic NMs use different tools to destroy microbial growth and thus prevent resistance patterns. Gold (Au), silver (Ag), zinc (Zn), copper (Cu), magnesium (Mg), and titanium make up the NMs (Ti). The combined use of Bismuth NM’s and X-rays is thought to be beneficial against bacteria that resist drug effects [108, 109]. It should be noted that Al2O3 NMs are thought to be free of drug resistance among metallic-NMs [110].

17 Application of silver nanoparticles

Ag nanoparticles perform different antimicrobial properties and are also responsible for suppressing microbial resistance in terms of growth. When silver is added to an aqueous solution, silver ions with a positive charge (Ag+) form, making it antimicrobial against a variety of bacteria [111]. The antimicrobial property of the Ag+ ion can be used in a variety of ways [112]. Initially, silver ions retaliate with groups of sulfur and phosphorous that carry proteins in the bacterial cell membrane and cell wall. Because the cell contains both negative and positive components, the silver ion attached to the negative part of the cell membrane creates a crack or hole within the membrane, allowing the cytoplasm content to escape. The cell’s demise is also caused by the gradient of hydrogen ions passing through the cell membrane. If this coordination between ions and cells does not occur, the Ag+ ion will pass through the cell membrane into the cytoplasm, and the cell wall will be responsible for the stronger action of the silver ion against bacteria. Because gram-negative bacteria are more sensitive to Ag+ ions than gram-positive bacteria, Ag+ ions are more effective against them. This sensitivity of bacteria may be due to a weak cell wall, which allows Ag ions to enter the bacterial cells [90]. Furthermore, these bacteria (gram +ive) are easily harmed by these ions (Ag+ ions) because they bind to the negatively charged LPS of gram negative, whereas gram positive contains peptidoglycan, which carries a positive charge. As a result, it was concluded that Ag+ ion, when treated against gram-positive and gram-negative bacteria, was less likely to probe gram-positive cells due to LPS [113].

Silver ions are also responsible for the formation of spume within bacterial cells [115]. Other responsibilities include: 1) preventing cytochrome from being removed from electron transport in microbes. 2) Completely eradicate microbial DNA and RNA. 3) Impaired cognitive microbes’ ability to copy DNA causes cell division to be delayed. 4) the presence of 30S ribosomal subunits, which suppress protein expression. 5) the formation of reactive oxygen species (ROS), which are extremely hazardous to eukaryotic cells and bacteria [116]. 6) Is also in charge of the production of gram-positive bacteria cell walls.

Ag-NMs have the ability to combat drug-resistant fungi, viruses, and bacteria, as well as some other broad-spectrum microbes. According to the literature, Ag NMs have bactericidal action against MDR bacteria such as P. aeruginosa, erythromycin-resistant S. pyogenes, and E. coli resistant to ampicillin [114, 117]. The effect of bactericidal drugs on various bacteria was studied, and the results show whether they are drug-resistant or drug-sensitive against bacteria. It was concluded that the fact that a protein exhibits antibiotic resistance does not change its susceptibility to Ag-NM [118]. The combination of antibacterial drugs and Ag NMs improves the antibacterial effectiveness of drugs used against E. coli and S. aureus, such as penicillin G, clindamycin, amoxicillin, vancomycin, and especially erythromycin. Wang et al. investigated the effect of Ag-NMs in conjunction with antibiotics such as levofloxacin, revealing a synergistic action with a favorable safety profile while studying animals [119]. This study also discovered that NMs of silver carbene complex wrappers were toxic to MDR bacteria [104]. According to the study, Ag-NM also has antiviral properties against HIV and HBV [120].

18 Zinc oxide nanoparticles

Zinc nanoparticles are used in a variety of applications to make microbes more resistant [121]. The medium in question is 1) widely used by others. Bacterial membranes are destroyed when they are strongly connected with zinc nanoparticles. As a result of the membranes being punctured, the cytoplasmic content is released from the cell, causing the cell to die. 2) When nanoparticles puncture bacteria cells, they produce zinc ions and reactive oxygen species (ROS) along with hydrogen peroxide (H2O2). When used in high concentrations, zinc nanoparticles have been shown to be toxic. It has antibacterial properties against MDR bacteria such as MRSA and methicillin-resistant bacteria [122, 123]. Pati et al. detected the existence of S. aureus in mice treated with ZnO NMs. Infection was caused in mice via the interadermal (ID) route, and zinc nanoparticles were used to treat the infection on the same day (S. aureus + zinc nanoparticles) or one day later.

19 Copper oxide nanoparticles

CuO nanoparticles have been used in two ways to combat microbial resistance [124]. 1) Within the microbial cell, Cu reacts with amine and carboxyl groups. CuO nanoparticles are effective against microbes with a high density and those with a group on the cell surface, such as B. subtilis. 2) Because of the increased concentration of copper ions, ROS are produced, which impedes amino acid synthesis and DNA replication within microbial cells [125, 126]. CuO-NPs have a weaker antibacterial effect but a stronger microbicide action against fungi. S. cerevisiae and other microbes such as Listeria monocytogenes, E. coli, and S. aureus are examples. This microbicide action is dependent on the shape and dose, i.e., the effect improves as the dose of CuO-NPs increases [127, 128]. The figure below depicts the destruction of copper nanoparticles (Figure 3).

Figure 3: 
The destruction of bacteria by application of Cu-NP incorporated MI-dPG surface coating via the “attract-kill-release” route. Copyright (2017) American Chemical Society [129].
Figure 3:

The destruction of bacteria by application of Cu-NP incorporated MI-dPG surface coating via the “attract-kill-release” route. Copyright (2017) American Chemical Society [129].

20 Titanium dioxide nanoparticles

Titanium dioxide nanoparticles use two methods against microbes, and the results show that TiO2-NPs have less resistance. The following are included in the systematic tool: When exposed to UV radiation, TiO2, which contains OH and H2O2 free radicals, generates ROS in a photocatalytic process. When TiO2 approaches microbes, the bacterial cell becomes punctured due to ROS, understanding membrane acceptability, encroaching oxidative-phosphorylation, and producing cell disfigurement [130, 131]. 2) Even if the cells have not been treated against irradiation, TiO2-NPs still exhibit bactericidal activity and other antimicrobial activity. Liu et al. noted that TiO2 101 and 001 contain valence bands and stunned conduction. The formation of a 101–001 surface heterotransition can produce quick photo electrons capable of transferring from (001) to (101), whereas the mess proceeds in another direction, resulting in a 3D separation of the electron-dump. In comparison to TiO2-NPs, they generate a lot of ROS and have a lot of antimicrobial action. In the test against E. coli and S. aureus, TiO2 NPs were used in the test, and their responses were recorded in the presence of sunlight and compared to controls [132].

21 Magnesium nanoparticles

Mg-NMs are made up of Mg halogen NPs (MgX2-NPs) and magnesium oxide NPs (MgO-NPs). These NPs are used in a variety of antimicrobial applications; their resistance is suspected in the following ways: 1) When metal halides are used, the enzymes in the bacterial cell are squeezed. 2) MgX2 is responsible for the generation of ROS, which results in the peroxidation of lipids in microbial cell membranes, and thus targets the cell’s cytoplasmic content [133]. 3) MgF2-NPs improve the lipid peroxidation process that occurs across the membrane of microbes (cells), resulting in a decrease in the pH of the cytoplasmic content and thus improving membrane capability. MgF2-NPs inhibit the production of biofilm by E. coli and S. aureus [134]. 4) Mg oxide inhibits microbes by attracting halogen molecules to the MgO surface. Because of its adsorption in MgO, wrapping Mg oxide in MgO-NPs increases the number of halogen molecules by up to five times, resulting in increased halogen action [135]. The activity of MgO NMs against Bacillus and E. coli increases due to Cl2 and Br2 communication with MgO-NMs, whereas this activity is lower for B. subtilis spores [136].

22 Gold nanoparticles

They are created through the use of various techniques, as previously demonstrated by research [137, 138]. Au-NPs do not have antibacterial activity on their own, but when combined with other antibiotics, they enhance their antibacterial properties [135, 136]. Brown et al. treated ampicillin binds to the surface of gold-NPs (Au-NPs-AMP) and terminates drug resistance in bacteria such as MRSA, E. coli, Enterobacter aerogenes, and P. aeruginosa [93]. When combined with antimicrobial substances [139], Au-NMs have a variety of properties that help to activate and increase antimicrobial activity when combined with them [140, 141]. Antibiotics (kanamycin and levofloxacin) in combination with Au-NPs upturn the activity of anti-bacterial [142, 143]. According to the literature, bacteria that lack the ability to endocytosis do not take AuNPs. Antibiotics (ampicillin) that inhibit cell wall function pass through the walls of G +ve and G −ve cells to provide antibacterial activity. The presence of ampicillin on Au-NMs allows NPs to enter bacterial cells. Scientists are still looking into two methods that worked together to kill bacteria. The presence of ampicillin molecules on the outer portion of Au-NM allowed Au-NM-AMP to inhibit lactamases. Furthermore, AuNPs, which extrude drug molecules from bacterial cells, obstruct transmembrane pumps [144].

23 Aluminum oxide nanoparticles

Al2O3-NPs are a type of metallic NM that has the ability to reverse drug resistance. According to the study [145], the Al2O3-Nps can also invade the cytoplasm of E. coli to cause a toxic effect. The higher the dose of Al2O3-Nps, the more it splits the cell walls of bacteria, but it also has a negligible effect on bacterial growth [146, 147]. This study also found that conjugating Al2O3-Nps with E. coli to salmonella increases the risk of antibiotic gene transmission by up to 200 times. It was determined that the bacterial gene is more resistant to one or more drugs. Qiu et al. reported that Al2O3-Nps causes the oxidative breakdown of bacteria’s cell membrane, which causes an increase in gene expression countersign communication and a decrease in gene inhibition coexistence.

24 Future prospective

The preceding studies demonstrate that nanoparticles can prevent and control biofilm formation. Some of the research looks into their mechanisms in vivo and in vitro. However, there are some challenges, such as biosafety, biocompatibility, adverse effects of systemic toxicity, target area, and nanoparticle concentration, which may be harmful to humans, plants, and animals. More research is needed to determine the toxicity of these nanoparticles in both terrestrial and aquatic environments.


Corresponding author: Hassan A. Hemeg, Department of Medical Laboratory Technology, College of Applied Medical Sciences, Taibah University, P.O. Box 344, Al-Madinah Al-Monawra 41411, Saudi Arabia, E-mail:

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Conflict of interest statement: The authors declare no conflicts of interest regarding this article.

References

1. Kassinger, SJ, vanHoek, ML. Biofilmarchitecture: an emerging synthetic biology target. Synth Syst Biotechnol 2020;5:1–10. https://doi.org/10.1016/j.synbio.2020.01.001.Search in Google Scholar PubMed PubMed Central

2. Hug, JJ, Krug, D, Müller, R. Bacteria as genetically programmable producers of bioactive natural products. Nat Rev Chem 2020;4:172–93. https://doi.org/10.1038/s41570-020-0176-1.Search in Google Scholar

3. Flemming, H-C, Wingender, J. The biofilm matrix. Nat Rev Microbiol 2010;8:623–33. https://doi.org/10.1038/nrmicro2415.Search in Google Scholar PubMed

4. Flemming, H-C, Wingender, J, Szewzyk, U, Steinberg, P, Rice, SA, Kjelleberg, S. Biofilms: an emergent form of bacterial life. Nat Rev Microbiol 2016;14:563–75. https://doi.org/10.1038/nrmicro.2016.94.Search in Google Scholar PubMed

5. Karygianni, L, Ren, Z, Koo, H, Thurnheer, T. Biofilm matrixome: extracellular components in structured microbial communities. Trends Microbiol 2020;28:668–81. https://doi.org/10.1016/j.tim.2020.03.016.Search in Google Scholar PubMed

6. Teirlinck, E, Samal, SK, Coenye, T, Braeckmans, K. Penetrating the bacterial biofilm: challenges for antimicrobial treatment. In: Boukherroub, R, Szunerits, S, Drider, D, editors. Functionalized nanomaterials for the management of microbial infection; Chapter 3. Boston, MA, USA: Elsevier; 2017:49–76 pp.10.1016/B978-0-323-41625-2.00003-XSearch in Google Scholar

7. Hobby, GL, Meyer, K, Chaffee, E. Observations on the mechanism of action of penicillin. Exp Biol Med 1942;50:281–5. https://doi.org/10.3181/00379727-50-13773.Search in Google Scholar

8. Bigger, JW. Treatment of staphylococcal infections with penicillin by intermittent sterilisation. Lancet 1944;244:497–500. https://doi.org/10.1016/s0140-6736(00)74210-3.Search in Google Scholar

9. Kwan, BW, Valenta, JA, Benedik, MJ, Wood, TK. Arrested protein synthesis increases persister-like cell formation. Antimicrob Agents Chemother 2013;57:1468–73. https://doi.org/10.1128/aac.02135-12.Search in Google Scholar PubMed PubMed Central

10. Pontes, MH, Groisman, EA. Slow growth determines nonheritable antibiotic resistance in Salmonella enterica. Sci Signal 2019;12:eaax3938. https://doi.org/10.1126/scisignal.aax3938.Search in Google Scholar PubMed PubMed Central

11. Kaldalu, N, Hauryliuk, V, Tenson, T. Persisters—as elusive as ever. Appl Microbiol Biotechnol 2016;100:6545–53. https://doi.org/10.1007/s00253-016-7648-8.Search in Google Scholar PubMed PubMed Central

12. Kudrin, P, Varik, V, Oliveira, SRA, Beljantseva, J, Del Peso Santos, T, Dzhygyr, I, et al.. Sub-inhibitory concentrations of bacteriostatic antibiotics induce relA-dependent and relA-independent tolerance to β-lactams. Antimicrob Agents Chemother 2017;61:e02173–16. https://doi.org/10.1128/aac.02173-16.Search in Google Scholar PubMed PubMed Central

13. Wood, TK, Knabel, SJ, Kwan, BW. Bacterial persister cell formation and dormancy. Appl Environ Microbiol 2013;79:7116–21. https://doi.org/10.1128/AEM.02636-13.Search in Google Scholar PubMed PubMed Central

14. Wood, TK, Song, S. Forming and waking dormant cells: the ppGpp ribosome dimerization persister model. Biofilm 2020;2:100018. https://doi.org/10.1016/j.bioflm.2019.100018.Search in Google Scholar PubMed PubMed Central

15. Wood, A, Irving, SE, Bennison, DJ, Corrigan, RM. The (p)ppGpp-binding GTPase Era promotes rRNA processing and cold adaptation in Staphylococcus aureus. PLoS Genet 2019;15:e1008346. https://doi.org/10.1371/journal.pgen.1008346.Search in Google Scholar PubMed PubMed Central

16. Kim, J-S, Chowdhury, N, Yamasaki, R, Wood, TK. Viable but non-culturable and persistence describe the same bacterial stress state. Environ Microbiol 2018a;20:2038–48. https://doi.org/10.1111/1462-2920.14075.Search in Google Scholar PubMed

17. Kim, J-S, Wood, TK. Persistent persister misperceptions. Front Microbiol 2016;7:2134. https://doi.org/10.3389/fmicb.2016.02134.Search in Google Scholar PubMed PubMed Central

18. Song, S, Wood, TK. Are we really studying persister cells? Environ Microbiol Rep 2020a May 3. https://doi.org/10.1111/1758-2229.12849 [Epub ahead of print].Search in Google Scholar PubMed

19. Song, S, Wood, TK. ppGpp ribosome dimerization model for bacterial persister formation and resuscitation. Biochem Biophys Res Commun 2020b;523:281–6. https://doi.org/10.1016/j.bbrc.2020.01.102.Search in Google Scholar PubMed

20. Hong, SH, Wang, X, O’Connor, HF, Benedik, MJ, Wood, TK. Bacterial persistence increases as environmental fitness decreases. Microbial Biotechnol 2012;5:509–22. https://doi.org/10.1111/j.1751-7915.2011.00327.x.Search in Google Scholar PubMed PubMed Central

21. Song, S, Wood, TK. Post-segregational killing and phage inhibition are not mediated by cell death through toxin/antitoxin systems. Front Microbiol 2018;9:814. https://doi.org/10.3389/fmicb.2018.00814.Search in Google Scholar PubMed PubMed Central

22. Dörr, T, Vulic, M, Lewis, K. Ciprofloxacin causes persister formation ´ by inducing the TisB toxin in Escherichia coli. PLoS Biol 2010;8:e1000317. https://doi.org/10.1371/journal.pbio.1000317.Search in Google Scholar PubMed PubMed Central

23. Möker, N, Dean, CR, Tao, J. Pseudomonas aeruginosa increases formation of multidrug-tolerant persister cells in response to quorum-sensing signaling molecules. J Bacteriol 2010;192:1946–55. https://doi.org/10.1128/jb.01231-09.Search in Google Scholar

24. Vega, NM, Allison, KR, Khalil, AS, Collins, JJ. Signaling-mediated bacterial persister formation. Nat Chem Biol 2012;8:431–3. https://doi.org/10.1038/nchembio.915.Search in Google Scholar PubMed PubMed Central

25. Kwan, BW, Osbourne, DO, Hu, Y, Benedik, MJ, Wood, TK. Phosphodiesterase DosP increases persistence by reducing cAMP which reduces the signal indole. Biotechnol Bioeng 2015;112:588–600. https://doi.org/10.1002/bit.25456.Search in Google Scholar PubMed

26. Hu, Y, Kwan, BW, Osbourne, DO, Benedik, MJ, Wood, TK. Toxin YafQ increases persister cell formation by reducing indole signalling. Environ Microbiol 2015;17:1275–85. https://doi.org/10.1111/1462-2920.12567.Search in Google Scholar PubMed

27. Lewis, K. Persister cells, dormancy and infectious disease. Nat Rev Microbiol 2007;5:48–56. https://doi.org/10.1038/nrmicro1557.Search in Google Scholar PubMed

28. Lewis, K. Multidrug tolerance of biofilms and persister cells. Curr Top Microbiol Immunol 2008;322:107–31. https://doi.org/10.1007/978-3-540-75418-3_6.Search in Google Scholar PubMed

29. Stoodley, P, Sauer, K, Davies, DG, Costerton, JW. Biofilms as complex differentiated communities. Annu Rev Microbiol 2002;56:187–209. https://doi.org/10.1146/annurev.micro.56.012302.160705.Search in Google Scholar PubMed

30. Flemming, HC, Wingender, J. The biofilm matrix. Nat Rev Microbiol 2010;8:623–33. https://doi.org/10.1038/nrmicro2415.Search in Google Scholar PubMed

31. Cegelski, L, Pinkner, JS, Hammer, ND, Cusumano, CK, Hung, CS, Chorell, E, et al.. Small-molecule inhibitors target Escherichia coli amyloid biogenesis and biofilm formation. Nat Chem Biol 2009;5:913–9. https://doi.org/10.1038/nchembio.242.Search in Google Scholar PubMed PubMed Central

32. Chorell, E, Bengtsson, C, Sainte-Luce Banchelin, T, Das, P, Uvell, H, Sinha, AK, et al.. Synthesis and application of a bromomethyl substituted scaffold to be used for efficient optimization of anti-virulence activity. Eur J Med Chem 2011;46:1103–16. https://doi.org/10.1016/j.ejmech.2011.01.025.Search in Google Scholar PubMed PubMed Central

33. Han, Z, Pinkner, JS, Ford, B, Obermann, R, Nolan, W, Wildman, SA, et al.. Structure-based drug design and optimization of mannoside bacterial FimH antagonists. J Med Chem 2010;53:4779–92. https://doi.org/10.1021/jm100438s.Search in Google Scholar PubMed PubMed Central

34. Qin, Z, Yang, L, Qu, D, Molin, S, Tolker-Nielsen, T. Pseudomonas aeruginosa extracellular products inhibit staphylococcal growth, and disrupt established biofilms produced by Staphylococcus epidermidis. Microbiology (Reading, Engl.) 2009;155:2148–56. https://doi.org/10.1099/mic.0.028001-0.Search in Google Scholar PubMed

35. Boyd, A, Chakrabarty, AM. Role of alginate lyase in cell detachment of Pseudomonas aeruginosa. Appl Environ Microbiol 1994;60:2355–9. https://doi.org/10.1128/aem.60.7.2355-2359.1994.Search in Google Scholar PubMed PubMed Central

36. Hughes, KA, Sutherland, IW, Jones, MV. Biofilm susceptibility to bacteriophage attack: the role of phage-borne polysaccharide depolymerase. Microbiology (Reading, Engl.) 1998;144:3039–47. https://doi.org/10.1099/00221287-144-11-3039.Search in Google Scholar PubMed

37. Kostakioti, M, Hadjifrangiskou, M, Hultgren, SJ. Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era. Cold Spring Harb Perspect Med 2013;3:a010306. https://doi.org/10.1101/cshperspect.a010306.Search in Google Scholar PubMed PubMed Central

38. Walsh, C. Molecular mechanisms that confer antibacterial drug resistance. Nature 2000;406:775–81. https://doi.org/10.1038/35021219.Search in Google Scholar PubMed

39. Brooks, BD, Brooks, AE. Therapeutic strategies to combat antibiotic resistance. Adv Drug Deliv Rev 2014;78:14–27. https://doi.org/10.1016/j.addr.2014.10.027.Search in Google Scholar PubMed

40. Walsh, C, Wright, G. Introduction: antibiotic resistance. Chem Rev 2005;105:391–4. https://doi.org/10.1021/cr030100y.Search in Google Scholar PubMed

41. Stewart, PS. Mechanisms of antibiotic resistance in bacterial biofilms. Int J Med Microbiol 2002;292:107–13. https://doi.org/10.1078/1438-4221-00196.Search in Google Scholar PubMed

42. Anderl, JN, Franklin, MJ, Stewart, PS. Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother 2000;44:1818–24. https://doi.org/10.1128/aac.44.7.1818-1824.2000.Search in Google Scholar PubMed PubMed Central

43. Walters, MC, Roe, F, Bugnicourt, A, Franklin, MJ, Stewart, PS. Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob Agents Chemother 2003;47:317–23. https://doi.org/10.1128/aac.47.1.317-323.2003.Search in Google Scholar

44. Taylor, PK, Yeung, ATY, Hancock, REW. Antibiotic resistance in Pseudomonas aeruginosa biofilms: towards the development of novel anti-biofilm therapies. J Biotechnol 2014;191:121–30. https://doi.org/10.1016/j.jbiotec.2014.09.003.Search in Google Scholar PubMed

45. Singh, R, Paul, D, Jain, RK. Biofilms: implications in bioremediation. Trends Microbiol 2006;14:389–97. https://doi.org/10.1016/j.tim.2006.07.001.Search in Google Scholar PubMed

46. Umadevi, S, Joseph, NM, Kumari, K, Easow, JM, Kumar, S, Stephen, S, et al.. Detection of extended spectrum beta lactamases, ampc beta lactamases and metallobetalactamases in clinical isolates of ceftazidime resistant Pseudomonas aeruginosa. Braz J Microbiol 2011;42:1284–8. https://doi.org/10.1590/s1517-83822011000400006.Search in Google Scholar

47. Drenkard, E. Antimicrobial resistance of Pseudomonas aeruginosa biofilms. Microb Infect 2003;5:1213–9. https://doi.org/10.1016/j.micinf.2003.08.009.Search in Google Scholar PubMed

48. Lewis, K. Persister cells and the riddle of biofilm survival. Biochemistry (Mosc) 2005;70:267–74. https://doi.org/10.1007/s10541-005-0111-6.Search in Google Scholar PubMed

49. Høiby, N, Bjarnsholt, T, Givskov, M, Molin, S, Ciofu, O. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 2010;35:322–32. https://doi.org/10.1016/j.ijantimicag.2009.12.011.Search in Google Scholar PubMed

50. Davies, DG, Parsek, MR, Pearson, JP, Iglewski, BH, Costerton, JW, Greenberg, EP. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 1998;280:295–8. https://doi.org/10.1126/science.280.5361.295.Search in Google Scholar PubMed

51. Parsek, MR, Greenberg, EP. Sociomicrobiology: the connections between quorum sensing and biofilms. Trends Microbiol 2005;13:27–33. https://doi.org/10.1016/j.tim.2004.11.007.Search in Google Scholar PubMed

52. Rasamiravaka, T, El Jaziri, M. Quorum-sensing mechanisms and bacterial response to antibiotics in P. aeruginosa. Curr Microbiol 2016;73:747–53. https://doi.org/10.1007/s00284-016-1101-1.Search in Google Scholar PubMed

53. Singh, PK, Schaefer, AL, Parsek, MR, Moninger, TO, Welsh, MJ, Greenberg, EP. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 2000;407:762–4. https://doi.org/10.1038/35037627.Search in Google Scholar PubMed

54. Maseda, H, Sawada, I, Saito, K, Uchiyama, H, Nakae, T, Nomura, N. Enhancement of the mexAB-oprM efflux pump expression by a quorum-sensing autoinducer and its cancellation by a regulator, MexT, of the mexEF-oprN efflux pump operon in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2004;48:1320–8. https://doi.org/10.1128/aac.48.4.1320-1328.2004.Search in Google Scholar

55. Rasamiravaka, T, Jaziri, ME. Quorum-sensing mechanisms and bacterial response to antibiotics in P. aeruginosa. Curr Microbiol 2016;73:747–53. https://doi.org/10.1007/s00284-016-1101-1.Search in Google Scholar

56. De Jong, WH, Borm, PJ. Drug delivery and nanoparticles: applications and hazards. Int J Nanomed 2008;3:133–49. https://doi.org/10.2147/ijn.s596.Search in Google Scholar PubMed PubMed Central

57. d’Angelo, I, Casciaro, B, Miro, A, Quaglia, F, Mangoni, ML, Ungaro, F. Overcoming barriers in Pseudomonas aeruginosa lung infections: engineered nanoparticles for local delivery of a cationic antimicrobial peptide. Colloids Surf B Biointerfaces 2015;135:717–25. https://doi.org/10.1016/j.colsurfb.2015.08.027.Search in Google Scholar PubMed

58. Hetrick, EM, Shin, JH, Paul, HS, Schoenfisch, MH. Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles. Biomaterials 2009;30:2782–9. https://doi.org/10.1016/j.biomaterials.2009.01.052.Search in Google Scholar PubMed PubMed Central

59. Abdelghany, SM, Quinn, DJ, Ingram, RJ, Gilmore, BF, Donnelly, RF, Taggart, CC, et al.. Gentamicin-loaded nanoparticles show improved antimicrobial effects towards Pseudomonas aeruginosa infection. Int J Nanomed 2012;7:4053–63. https://doi.org/10.2147/IJN.S34341.Search in Google Scholar PubMed PubMed Central

60. Shrestha, A, Hamblin, MR, Kishen, A. Photoactivated rose bengal functionalized chitosan nanoparticles produce antibacterial/biofilm activity and stabilize dentin-collagen. Nanomed Nanotechnol Biol Med 2014;10:491–501. https://doi.org/10.1016/j.nano.2013.10.010.Search in Google Scholar PubMed PubMed Central

61. Taylor, EN, Kummer, KM, Durmus, NG, Leuba, K, Tarquinio, KM, Webster, TJ. Superparamagnetic iron oxide nanoparticles (SPION) for the treatment of antibiotic-resistant biofilms. Small 2012;8:3016–27. https://doi.org/10.1002/smll.201200575.Search in Google Scholar PubMed

62. Durmus, NG, Taylor, EN, Kummer, KM, Webster, TJ. Enhanced efficacy of superparamagnetic iron oxide nanoparticles against antibiotic-resistant biofilms in the presence of metabolites. Adv Mater 2013;25:5706–13. https://doi.org/10.1002/adma.201302627.Search in Google Scholar PubMed

63. Gao, L, Giglio, KM, Nelson, JL, Sondermann, H, Travis, AJ. Ferromagnetic nanoparticles with peroxidase-like activity enhance the cleavage of biological macromolecules for biofilm elimination. Nanoscale 2014;6:2588–93. https://doi.org/10.1039/c3nr05422e.Search in Google Scholar PubMed PubMed Central

64. Thukkaram, M, Sitaram, S, Kannaiyan, SK, Subbiahdoss, G. Antibacterial efficacy of iron-oxide nanoparticles against biofilms on different biomaterial surfaces. Int J Biomater 2014;2014:716080. https://doi.org/10.1155/2014/716080.Search in Google Scholar PubMed PubMed Central

65. Mohanty, S, Mishra, S, Jena, P, Jacob, B, Sarkar, B, Sonawane, A. An investigation on the antibacterial, cytotoxic, and antibiofilm efficacy of starch-stabilized silver nanoparticles. Nanomed Nanotechnol Biol Med 2012;8:916–24. https://doi.org/10.1016/j.nano.2011.11.007.Search in Google Scholar PubMed

66. Jaiswal, S, Bhattacharya, K, McHale, P, Duffy, B. Dual effects of β-cyclodextrin-stabilised silver nanoparticles: enhanced biofilm inhibition and reduced cytotoxicity. J Mater Sci Mater Med 2015;26:1–10. https://doi.org/10.1007/s10856-014-5367-1.Search in Google Scholar PubMed

67. Cheow, WS, Hadinoto, K. Lipid-polymer hybrid nanoparticles with rhamnolipid-triggered release capabilities as anti-biofilm drug delivery vehicles. Particuology 2012;10:327–33. https://doi.org/10.1016/j.partic.2011.08.007.Search in Google Scholar

68. Sun, L, Zhang, C, Li, P. Characterization, antibiofilm, and mechanism of action of novel PEG-stabilized lipid nanoparticles loaded with terpinen-4-ol. J Agric Food Chem 2012;60:6150–6. https://doi.org/10.1021/jf3010405.Search in Google Scholar PubMed

69. Suresh, AK, Pelletier, DA, Doktycz, MJ. Relating nanomaterial properties and microbial toxicity. Nanoscale 2013;5:463–74. https://doi.org/10.1039/c2nr32447d.Search in Google Scholar PubMed

70. Li, M, Zhu, LZ, Lin, DH. Toxicity of ZnO nanoparticles to Escherichia coli: mechanism and the influence of medium components. Environ Sci Technol 2011a;45:1977–83. https://doi.org/10.1021/es102624t.Search in Google Scholar PubMed

71. Sotiriou, GA, Pratsinis, SE. Antibacterial activity of nanosilver ions and particles. Environ Sci Technol 2010;44:5649–54. https://doi.org/10.1021/es101072s.Search in Google Scholar PubMed

72. Marambio-Jones, C, Hoek, EMV. A review of the antibacterial effects of silver nanomaterials and potential implications for human health and the environment. J Nanoparticle Res 2010;12:1531–51. https://doi.org/10.1007/s11051-010-9900-y.Search in Google Scholar

73. Karimi, E, Mohseni Fard, E. Nanomaterial effects on soil microorganisms. In: Ghorbanpour, M, Manika, K, Varma, A, editors. Nanoscience and plant–soil systems, soil biology. Cham: Springer; 2017, vol 48:137–200 pp.10.1007/978-3-319-46835-8_5Search in Google Scholar

74. Hoseinzadeh, E, Makhdoumi, P, Taha, P, Hossini, H, Stelling, J, Kamal, MA, et al.. A review on nano antimicrobials: metal nanoparticles, methods and mechanisms. Curr Drug Metabol 2017;18:120–8. https://doi.org/10.2174/1389200217666161201111146.Search in Google Scholar PubMed

75. Ben-Sasson, M, Zodrow, KR, Genggeng, Q, Kang, Y, Giannelis, EP, Elimelech, M. Surface functionalization of thin-film composite membranes with copper nanoparticles for antimicrobial surface properties. Environ Sci Technol 2014;48:384–93. https://doi.org/10.1021/es404232s.Search in Google Scholar PubMed

76. Rajakumar, G, Rahuman, AA, Roopan, SM, Gopiesh Khanna, V, Elango, G, Kamaraj, C, et al.. Fungus-mediated biosynthesis and characterization of TiO2 nanoparticles and their activity against pathogenic bacteria. Spectrochim Acta A Mol Biomol Spectrosc 2012;91:23–9. https://doi.org/10.1016/j.saa.2012.01.011.Search in Google Scholar PubMed

77. Sukhorukova, IV, Sheveyko, AN, Kiryukhantsev-Korneev, PV, Zhitnyak, IY, Gloushankova, NA, Denisenko, EA, et al.. Toward bioactive yet antibacterial surfaces. Colloids Surf, B 2015;135:158–65. https://doi.org/10.1016/j.colsurfb.2015.06.059.Search in Google Scholar PubMed

78. Pan, X, Wang, Y, Chen, Z, Pan, D, Cheng, Y, Liu, Z, et al.. Investigation of antibacterial activity and related mechanism of a series of nano-Mg(OH)2. ACS Appl Mater Interfaces 2013;5:1137–42. https://doi.org/10.1021/am302910q.Search in Google Scholar PubMed

79. Arakha, M, Pal, S, Samantarrai, D, Panigrahi, TK, Mallick, BC, Pramanik, K, et al.. Antimicrobial activity of iron oxide nanoparticle upon modulation of nanoparticle-bacteria interface. Sci Rep 2015;5:14813. https://doi.org/10.1038/srep14813.Search in Google Scholar PubMed PubMed Central

80. Wang, L, Hu, C, Shao, L. The antimicrobial activity of nanoparticles: present situation and prospects for the future. Int J Nanomed 2017;12:1227–49. https://doi.org/10.2147/ijn.s121956.Search in Google Scholar PubMed PubMed Central

81. El-Badawy, AM, Luxton, TP, Silva, RG, Scheckel, KG, Suidan, MT, Tolaymat, TM. Impact of environmental conditions (pH, ionic strength, and electrolyte type) on the surface charge and aggregation of silver nanoparticles suspensions. Environ Sci Technol 2010;44:1260–6. https://doi.org/10.1021/es902240k.Search in Google Scholar PubMed

82. Yoon, KY, Byeon, JH, Park, JH, Hwang, J. Susceptibility constants of Escherichia coli and Bacillus subtilis to silver and copper nanoparticles. Sci Total Environ 2007;373:572–5. https://doi.org/10.1016/j.scitotenv.2006.11.007.Search in Google Scholar PubMed

83. Brayner, R, Ferrari-Iliou, R, Brivois, N, Djediat, S, Benedetti, MF, Fiévet, F. Toxicological impact studies based on Escherichia coli bacteria in ultrafine ZnO nanoparticles colloidal medium. Nano Lett 2006;6:866–70. https://doi.org/10.1021/nl052326h.Search in Google Scholar PubMed

84. Qi, L, Xu, Z, Jiang, X, Hu, C, Zou, X. Preparation and antibacterial activity of chitosan nanoparticles. Carbohydr Res 2004;339:2693–700. https://doi.org/10.1016/j.carres.2004.09.007.Search in Google Scholar PubMed

85. Dumas, E, Gao, C, Suffern, D, Bradforth, SE, Dimitrijevic, NM, Nadeau, JL. Interfacial charge transfer between CdTe quantum dots and gram negative versus gram positive bacteria. Environ Sci Technol 2010;44:1464–70. https://doi.org/10.1021/es902898d.Search in Google Scholar PubMed

86. Mah, TFC, O’Toole, GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 2001;9:34–9. https://doi.org/10.1016/s0966-842x(00)01913-2.Search in Google Scholar PubMed

87. Lu, C. Slow growth induces heat-shock resistance in normal and respiratory-deficient yeast. Mol Biol Cell 2009;20:891–903. https://doi.org/10.1091/mbc.e08-08-0852.Search in Google Scholar PubMed PubMed Central

88. Wu, B. Bacterial responses to Cu-doped TiO2 nanoparticles. Sci Total Environ 2010;408:1755–8. Yamamoto O. Influence of particle size on the antibacterial activity of zinc oxide. Int J Inorg Mater 2001;3:643–6.10.1016/j.scitotenv.2009.11.004Search in Google Scholar PubMed

89. Simon-Deckers, A, Loo, S, Mayne-L’hermite, M, Herlin-Boime, N, Menguy, N, Reynaud, C, et al.. Size-, composition- and shape-dependent toxicological impact of metal oxide nanoparticles and carbon nanotubes toward bacteria. Environ Sci Technol 2009;43:8423–9. https://doi.org/10.1021/es9016975.Search in Google Scholar PubMed

90. Hajipour, MJ, Fromm, KM, Ashkarran, AA, De Aberasturi, D, De Larramendi, IR, Rojo, T, et al.. Antibacterial properties of nanoparticles. Trends Biotechnol 2012;30:499–511. https://doi.org/10.1016/j.tibtech.2012.06.004.Search in Google Scholar PubMed

91. Korch, SB, Henderson, TA, Hill, TM. Characterization of the hipA7 allele of Escherichia coli and evidence that high persistence is governed by (p)ppGpp synthesis. Mol Microbiol 2003;50:1199–213. https://doi.org/10.1046/j.1365-2958.2003.03779.x.Search in Google Scholar PubMed

92. Nguyen, D, Joshi-Datar, A, Lepine, F, Bauerle, E, Olakanmi, O, Beer, K, et al.. Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria. Science 2011;334:982–6. https://doi.org/10.1126/science.1211037.Search in Google Scholar PubMed PubMed Central

93. Chowdhury, N, Kwan, BW, Wood, TK. Persistence increases in the absence of the alarmone guanosine tetraphosphate by reducing cell growth. Sci Rep 2016a;6:20519. https://doi.org/10.1038/srep20519.Search in Google Scholar PubMed PubMed Central

94. Svenningsen, MS, Veress, A, Harms, A, Mitarai, N, Semsey, S. Birth and resuscitation of (p)ppGpp induced antibiotic tolerant persister cells. Sci Rep 2019;9:6056. https://doi.org/10.1038/s41598-019-42403-7.Search in Google Scholar PubMed PubMed Central

95. Gaca, AO, Colomer-Winter, C, Lemos, JA. Many means to a common end: the intricacies of (p)ppGpp metabolism and its control of bacterial homeostasis. J Bacteriol 2015;197:1146–56. https://doi.org/10.1128/jb.02577-14.Search in Google Scholar PubMed PubMed Central

96. Dalebroux, ZD, Swanson, MS. ppGpp: magic beyond RNA polymerase. Nat Rev Microbiol 2012;10:203–12. https://doi.org/10.1038/nrmicro2720.Search in Google Scholar PubMed

97. Wang, B, Dai, P, Ding, D, Del Rosario, A, Grant, RA, Pentelute, BL, et al.. Affinity-based capture and identification of protein effectors of the growth regulator ppGpp. Nat Chem Biol 2019;15:141–50. https://doi.org/10.1038/s41589-018-0183-4.Search in Google Scholar PubMed PubMed Central

98. Zhang, YE, Bærentsen, RL, Fuhrer, T, Sauer, U, Gerdes, K, Brodersen, DE. (p)ppGpp regulates a bacterial nucleosidase by an allosteric two-domain switch. Mol Cell 2019;74:1239.e4–49.e4. https://doi.org/10.1016/j.molcel.2019.03.035.Search in Google Scholar PubMed

99. Shimada, T, Yoshida, H, Ishihama, A. Involvement of cyclic AMP receptor protein in regulation of the rmf gene encoding the ribosome modulation factor in Escherichia coli. J Bacteriol 2013b;195:2212–9. https://doi.org/10.1128/jb.02279-12.Search in Google Scholar PubMed PubMed Central

100. Izutsu, K, Wada, A, Wada, C. Expression of ribosome modulation factor (RMF) in Escherichia coli requires ppGpp. Gene Cell 2001;6:665–76. https://doi.org/10.1046/j.1365-2443.2001.00457.x.Search in Google Scholar PubMed

101. Maisonneuve, E, Castro-Camargo, M, Gerdes, K. Retraction notice to: (p)ppGpp controls bacterial persistence by stochastic induction of toxinantitoxin activity. Cell 2018a;172:1135. https://doi.org/10.1016/j.cell.2018.02.023.Search in Google Scholar PubMed

102. Maisonneuve, E, Shakespeare, LJ, Jørgensen, MG, Gerdes, K. Retraction for Maisonneuve et al bacterial persistence by RNA endonucleases. Proc Natl Acad Sci USA 2018b;115:E2901. https://doi.org/10.1073/pnas.1803278115.Search in Google Scholar PubMed PubMed Central

103. Maisonneuve, E, Roghanian, M, Gerdes, K, Germain, E. Retraction for Germain et al. stochastic induction of persister cells by HipA through (p)ppGpp-mediated activation of mRNA endonucleases. Proc Natl Acad Sci USA 2019;116:11077. https://doi.org/10.1073/pnas.1906160116.Search in Google Scholar PubMed PubMed Central

104. Conlon, BP, Rowe, SE, Gandt, AB, Nuxoll, AS, Donegan, NP, Zalis, EA, et al.. Persister formation in Staphylococcus aureus is associated with ATP depletion. Nat Microbiol 2016;1:16051. https://doi.org/10.1038/nmicrobiol.2016.51.Search in Google Scholar PubMed PubMed Central

105. Goormaghtigh, F, Fraikin, N, Putrinš, M, Hallaert, T, Hauryliuk, V, GarciaPino, A, et al.. Reassessing the role of type II toxin-antitoxin systems in formation of Escherichia coli type II persister cells. mBio 2018;9:e00640–18. https://doi.org/10.1128/mBio.00640-18.Search in Google Scholar PubMed PubMed Central

106. Prossliner, T, Winther, KS, Sørensen, MA, Gerdes, K. Ribosome hibernation. Annu Rev Genet 2018;52:321–48. https://doi.org/10.1146/annurev-genet-120215-035130.Search in Google Scholar PubMed

107. Lin, HH, Hsu, CC, Yang, CD, Ju, YW, Chen, YP, Tseng, CP. Negative effect of glucose on ompA mRNA stability: a potential role of cyclic AMP in the repression of hfq in Escherichia coli. J Bacteriol 2011;193:5833–40. https://doi.org/10.1128/jb.05359-11.Search in Google Scholar

108. Wyszogrodzka, G, Marszałek, B, Gil, B, Dorożyński, P. Metalorganic frameworks: mechanisms of antibacterial action and potential applications. Drug Discov Today 2016;21:1009–18. https://doi.org/10.1016/j.drudis.2016.04.009.Search in Google Scholar PubMed

109. Luo, Y, Hossain, M, Wang, C, Qiao, Y, An, J, Ma, L, et al.. Targeted nanoparticles for enhanced X-ray radiation killing of multidrug-resistant bacteria. Nanoscale 2013;5:687–94. https://doi.org/10.1039/C2NR33154C.Search in Google Scholar

110. Qiu, Z, Yu, Y, Chen, Z, Jin, M, Yang, D, Zhao, Z, et al.. Nanoalumina promotes the horizontal transfer of multi resistance genes mediated by plasmids across genera. Proc Natl Acad Sci USA 2012;109:4944–9. https://doi.org/10.1073/pnas.1107254109.Search in Google Scholar PubMed PubMed Central

111. Ramalingam, B, Parandhaman, T, Das, SK. Antibacterial effects of biosynthesized silver nanoparticles on surface ultrastructure and nanomechanical properties of gram-negative bacteria viz. escherichia coli and pseudomonas aeruginosa. ACS Appl Mater Interfaces 2016;8:4963–76. https://doi.org/10.1021/acsami.6b00161.Search in Google Scholar PubMed

112. Dakal, TC, Kumar, A, Majumdar, RS, Yadav, V. Mechanistic basis of antimicrobial actions of silver nanoparticles. Front Microbiol 2016;7:1831. https://doi.org/10.3389/fmicb.2016.01831.Search in Google Scholar PubMed PubMed Central

113. Song, Z, Wu, Y, Wang, H, Han, H. Synergistic antibacterial effects of curcumin modified silver nanoparticles through ROS-mediated pathways. Mater Sci Eng C 2019;99:255–63. https://doi.org/10.1016/j.msec.2018.12.053.Search in Google Scholar PubMed

114. Lister, PD, Wolter, DJ, Hanson, ND. Antibacterial-resistant pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev 2009;22:582–610. https://doi.org/10.1128/cmr.00040-09.Search in Google Scholar

115. Mahmoudi, M, Serpooshan, V. Silver-coated engineered magnetic nanoparticles are promising for the success in the fight against antibacterial resistance threat. ACS Nano 2012;6:2656–64. https://doi.org/10.1021/nn300042m.Search in Google Scholar PubMed

116. Brown, AN, Smith, K, Samuels, TA, Lu, J, Obare, SO, Scott, ME. Nanoparticles functionalized with ampicillin destroy multipleantibiotic-resistant isolates of pseudomonas aeruginosa and enterobacter aerogenes and methicillin-resistant staphylococcus aureus. Appl Environ Microbiol 2012;78:2768–74. https://doi.org/10.1128/AEM.06513-11.Search in Google Scholar PubMed PubMed Central

117. Kim, JS, Kuk, E, Yu, KN, Kim, JH, Park, SJ, Lee, HJ, et al.. Antimicrobial effects of silver nanoparticles. Nanomed Nanotechnol Biol Med 2007;3:95–101. https://doi.org/10.1016/j.nano.2006.12.001.Search in Google Scholar PubMed

118. Wang, Y, Ding, X, Chen, Y, Guo, M, Zhang, Y, Guo, X, et al.. Antibiotic-loaded, silver coreembedded mesoporous silica nanovehicles as a synergistic antibacterial agent for the treatment of drug-resistant infections. Biomaterials 2016;101:207–16. https://doi.org/10.1016/j.biomaterials.2016.06.004.Search in Google Scholar PubMed

119. Rai, M, Deshmukh, SD, Ingle, AP, Gupta, IR, Galdiero, M, Galdiero, S. The protective nanoshield against virus infection. Crit Rev Microbiol 2016;42:46–56. https://doi.org/10.3109/1040841X.2013.879849.Search in Google Scholar PubMed

120. Sirelkhatim, A, Mahmud, S, Seeni, A, Kaus, NHM, Ann, LC, Bakhori, SKM, et al.. Review on zinc oxide nanoparticles: antibacterial activity and toxicity mechanism. Nano-Micro Lett 2015;7:219–42. https://doi.org/10.1007/s40820-015-0040-x.Search in Google Scholar PubMed PubMed Central

121. Kadiyala, U, Turali-Emre, ES, Bahng, JH, Kotov, NA, VanEpps, JS. Unexpected insights into antibacterial activity of zinc oxide nanoparticles against methicillin resistant staphylococcus aureus (MRSA). Nanoscale 2018;10:4927–39. https://doi.org/10.1039/C7NR08499D.Search in Google Scholar PubMed PubMed Central

122. Ramani, M, Ponnusamy, S, Muthamizhchelvan, C. From zinc oxide nanoparticles to microflowers: a study of growth kinetics and biocidal activity. Mater Sci Eng C 2012;32:2381–9. https://doi.org/10.1016/j.msec.2012.07.011.Search in Google Scholar

123. Meghana, S, Kabra, P, Chakraborty, S, Padmavathy, N. Understanding the pathway of antibacterial activity of copper oxide nanoparticles. RSC Adv 2015;5:12293–9. https://doi.org/10.1039/C4RA12163E.Search in Google Scholar

124. Hassan, MS, Amna, T, Yang, O-B, El-Newehy, MH, Al-Deyab, SS, Khil, M-S. Smart copper oxide nanocrystals: synthesis, characterization, electrochemical and potent antibacterial activity. Colloids Surf B Biointerfaces 2012;97:201–6. https://doi.org/10.1016/j.colsurfb.2012.04.032.Search in Google Scholar PubMed

125. Ananth, A, Dharaneedharan, S, Heo, M-S, Mok, YS. Copper oxide nanomaterials: synthesis, characterization and structure-specific antibacterial performance. Chem Eng J 2015;262:179–88. https://doi.org/10.1016/j.cej.2014.09.083.Search in Google Scholar

126. Azam, A, Ahmed, AS, Oves, M, Khan, MS, Memic, A. Size-dependent antimicrobial properties of CuO nanoparticles against grampositive and-negative bacterial strains. Int J Nanomed 2012;7:3527. https://doi.org/10.2147/IJN.S29020.Search in Google Scholar PubMed PubMed Central

127. Laha, D, Pramanik, A, Laskar, A, Jana, M, Pramanik, P, Karmakar, P. Shape-dependent bactericidal activity of copper oxide nanoparticle mediated by DNA and membrane damage. Mater Res Bull 2014;59:185–91. https://doi.org/10.1016/j.materresbull.2014.06.024.Search in Google Scholar

128. Li, M, Gao, L, Schlaich, C, Zhang, J, Donskyi, IS, Yu, G, et al.. Construction of functional coatings with durable and broad-spectrum antibacterial potential based on mussel-inspired dendritic polyglycerol and in situformed copper nanoparticles. ACS Appl Mater Interfaces 2017;9:35411–8. https://doi.org/10.1021/acsami.7b10541.Search in Google Scholar PubMed

129. Ranjan, S, Ramalingam, C. Titanium dioxide nanoparticles induce bacterial membrane rupture by reactive oxygen species generation. Environ Chem Lett 2016;14:487–94. https://doi.org/10.1007/s10311-016-0586-y.Search in Google Scholar

130. Huang, Y-Y, Choi, H, Kushida, Y, Bhayana, B, Wang, Y, Hamblin, MR. Broad-spectrum antimicrobial effects of photocatalysis using titanium dioxide nanoparticles are strongly potentiated by addition of potassium iodide. Antimicrob Agents Chemother 2016;60:5445–53. https://doi.org/10.1128/AAC.00980-16.Search in Google Scholar PubMed PubMed Central

131. Liu, N, Chang, Y, Feng, Y, Cheng, Y, Sun, X, Jian, H, et al.. {101}–{001} surface heterojunction-enhanced antibacterial activity of titanium dioxide nanocrystals under sunlight irradiation. ACS Appl Mater Interfaces 2017;9:5907–15. https://doi.org/10.1021/acsami.6b16373.Search in Google Scholar PubMed

132. Blecher, K, Nasir, A, Friedman, A. The growing role of nanotechnology in combating infectious disease. Virulence 2011;2:395–401. https://doi.org/10.4161/viru.2.5.17035.Search in Google Scholar PubMed

133. Lellouche, J, Friedman, A, Lahmi, R, Gedanken, A, Banin, E. Antibiofilm surface functionalization of catheters by magnesium fluoride nanoparticles. Int J Nanomed 2012;7:1175. https://doi.org/10.2147/IJN.S26770.Search in Google Scholar PubMed PubMed Central

134. Stoimenov, PK, Klinger, RL, Marchin, GL, Klabunde, KJ. Metal oxide nanoparticles as bactericidal agents. Langmuir 2002;18:6679–86. https://doi.org/10.1021/la0202374.Search in Google Scholar

135. Haggstrom, JA, Klabunde, KJ, Marchin, GL. Biocidal properties of metal oxide nanoparticles and their halogen adducts. Nanoscale 2010;2:399–405. https://doi.org/10.1039/B9NR00245F.Search in Google Scholar

136. Shedbalkar, U, Singh, R, Wadhwani, S, Gaidhani, S, Chopade, BA. Microbial synthesis of gold nanoparticles: current status and future prospects. Adv Colloid Interface Sci 2014;209:40–8. https://doi.org/10.1016/j.cis.2013.12.011.Search in Google Scholar PubMed

137. Suresh, AK, Pelletier, DA, Wang, W, Broicha, ML, Moon, JW, Gu, B, et al.. Biofabrication of discrete spherical gold nanoparticles using the metal-reducing bacterium shewanella oneidensis. Acta Biomater 2011;7:2148–52. https://doi.org/10.1016/j.actbio.2011.01.023.Search in Google Scholar PubMed

138. Rai, A, Prabhune, A, Perry, CC. Antibiotic mediated synthesis of gold nanoparticles with potent antimicrobial activity and their application in antimicrobial coatings. J Mater Chem 2010;20:6789–98. https://doi.org/10.1039/c0jm00817f.Search in Google Scholar

139. Feng, Y, Chen, W, Jia, Y, Tian, Y, Zhao, Y, Long, F, et al.. N-heterocyclic molecule-capped gold nanoparticles as effective antibiotics against multi-drug resistant bacteria. Nanoscale 2016;8:13223–7. https://doi.org/10.1039/C6NR03317B.Search in Google Scholar

140. Khan, F, Kang, M-G, Jo, D-M, Chandika, P, Jung, W-K, Kang, HW, et al.. Phloroglucinol-gold and -zinc oxide nanoparticles: antibiofilm and antivirulence activities towards Pseudomonas aeruginosa PAO1. Mar Drugs 2021;19:601. https://doi.org/10.3390/md19110601.Search in Google Scholar PubMed PubMed Central

141. Torres, MR, Slate, AJ, Ryder, SF, Akram, M, Iruzubieta, CJC, Whitehead, KA. Ionic gold demonstrates antimicrobial activity against Pseudomonas aeruginosa strains due to cellular ultrastructure damage. Arch Microbiol 2021;203:3015–24. https://doi.org/10.1007/s00203-021-02270-1.Search in Google Scholar PubMed PubMed Central

142. Zhao, Y, Jiang, X. Multiple strategies to activate gold nanoparticles as antibiotics. Nanoscale 2013;5:8340–50. https://doi.org/10.1039/c3nr01990j.Search in Google Scholar PubMed

143. Bagga, P, Hussain Siddiqui, H, Akhtar, J, Mahmood, T, Zahera, M, Sajid Khan, M. Gold nanoparticles conjugated levofloxacin: for improved antibacterial activity over levofloxacin alone. Curr Drug Deliv 2017;14:1114–9. https://doi.org/10.2174/1567201814666170316113432.Search in Google Scholar PubMed

144. Payne, JN, Waghwani, HK, Connor, MG, Hamilton, W, Tockstein, S, Moolani, H, et al.. Novel synthesis of kanamycin conjugated gold nanoparticles with potent antibacterial activity. Front Microbiol 2016;7:607. https://doi.org/10.3389/fmicb.2016.00607.Search in Google Scholar PubMed PubMed Central

145. Cui, Y, Zhao, Y, Tian, Y, Zhang, W, Lü, X, Jiang, X. The molecular mechanism of action of bactericidal gold nanoparticles on Escherichia coli. Biomaterials 2012;33:2327–33. https://doi.org/10.1016/j.biomaterials.2011.11.057.Search in Google Scholar PubMed

146. Sadiq, IM, Chowdhury, B, Chandrasekaran, N, Mukherjee, A. Antimicrobial sensitivity of escherichia coli to alumina nanoparticles. Nanomed Nanotechnol Biol Med 2009;5:282–6. https://doi.org/10.1016/j.nano.2009.01.002.Search in Google Scholar PubMed

147. Huh, AJ, Kwon, YJ. “Nanoantibiotics”: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. J Contr Release 2011;156:128–45. https://doi.org/10.1016/j.jconrel.2011.07.002.Search in Google Scholar PubMed

Received: 2021-11-24
Accepted: 2022-02-04
Published Online: 2022-03-01
Published in Print: 2022-09-27

© 2022 Hassan A. Hemeg, published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Downloaded on 3.6.2024 from https://www.degruyter.com/document/doi/10.1515/znc-2021-0296/html
Scroll to top button